Hepatocellular Carcinoma
Conditions
Brief summary
Clinical research of Yang Yin Fu Zheng Jie Du therapy in recurrence of Hepatocellular Carcinoma less than 3 cm in diameter.The purpose of this study is to observe the efficacy of routine medical care combined with Yang Yin Fu Zheng Jie Du therapy in 1 year recurrence for patients belong to Hepatocellular Carcinoma less than 3 cm in diameter.
Interventions
Yang Yin Fu Zheng Jie Du is a Chinese herbal compound.
OTHERRoutine medical care
Routine medical care
Sponsors
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Beijing Ditan Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Meet the criteria of hepatocellular carcinoma * Ages Eligible for Study: ≤75 years old; * The size of the main nodule and multi-centricity (single lesion, three nodules ≤3 cm) * After transarterial chemoembolisation (TACE) or radiofrequency ablation (RFA) * Surgery cannot be allowed; * Informed consent from the patient.
Exclusion criteria
* Serious problem of heart, lung, or kidney with severe dysfunction; * Pregnant or child breast feeding women; * Mental or cognitive disorders; * Participating in other drug trials; * Who are allergic to the study drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrance rate | 1 year |
Secondary
| Measure | Time frame |
|---|---|
| Objective response rate | 1 year |
| quality of life (QOL) questionnaire | 1 year |
Countries
China
Outcome results
None listed